Graphic from the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV).
The medical workers at 100 locations nationwide, including national hospitals, will be the first to receive a COVID-19 vaccine developed by major US drugmaker Pfizer Inc.
"This is also the meaning of the slogan of the National Covid-19 Immunisation Programme that I officially launched today (yesterday), which is Protect Oneself, Protect Everyone", he said.
The first phase of Malaysia's vaccination drive will run from February to April, and involve 300,000 medical and 200,000 non-medical frontline workers - including politicians, security and welfare officers, Science Minister Khairy Jamaluddin told reporters after the launch.
Front-line healthcare workers will be the first to be vaccinated, followed by those over 80 years old. So far, the government has provided conditional approval to just Pfizer-BioNtech for its vaccine.
According to excerpts of his speech released in advance to the press, the United Kingdom foreign secretary will also use the UK's presidency of the Security Council this month to warn members that allowing the virus to spread in areas without vaccination campaigns means a greater risk of new variants taking hold and further waves sweeping the world.
"We will also have protocols in place if excess doses are not used".
Supplies of imported vaccines are a major concern because of supply shortages and restrictions in Europe, where many are manufactured.
The Pfizer vaccines cover 50 per cent of the population, AstraZeneca (20 per cent), Sinovac (18.75 per cent), CanSinoBio (10.9 per cent), and Sputnik V (10 per cent).
The prime minister also urged all in the country not to treat the vaccination programme lightly, saying its success was essential in order for the country to return to social and economic normalcy.
Nigerian government planned to vaccinate approximately 109 million citizens that will be eligible for the Covid-19 vaccination in two years, a senior health official has said. However, the Ministry of Health will update the contraindications from time to time. Their commitments are critical to the timely and secure delivery of vaccines and critical supplies.
Local pharmaceutical company Pharmaniaga will be carrying out the fill-and-finish process for the Sinovac vaccine and Duopharma will be doing the fill-and-finish process for the Russian Sputnik V vaccine.